ATC CODE
- M03AX01
INDICATIONS AND NEMLC RECOMMENDATIONS
INDICATIONS AND NEMLC RECOMMENDATIONS 1
INDICATION
- Focal dystonias.
NEMLC RECOMMENDATION
- Approved for use in carefully selected patients.
Only to be administered by suitably experienced practitioners.
REVIEW INDICATORS
- New evidence with clinical relevant/well defined endpoints and well described dosage regimens.
DATE RATIFIED
- 30 June 2016
INDICATIONS AND NEMLC RECOMMENDATIONS 2
INDICATION
- Spastic cerebral palsy.
NEMLC RECOMMENDATION
- Not Approved .
REVIEW INDICATORS
- New evidence with clinical relevant/well defined endpoints and well described dosage regimens.
DATE RATIFIED
- Re-review: 30 June 2016